Lists
Lists
Nuttall, Dilyse 
ORCID: 0000-0002-0561-5229
(2016)
Cardiovascular disease and lipid-regulating drugs.
Nurse Prescribing, 14
(5).
p. 224.
ISSN 2052-2924
Preview |
PDF (Author Accepted Manuscript)
- Accepted Version
Available under License Creative Commons Attribution Non-commercial No Derivatives. 347kB |
Official URL: https://doi.org/10.12968/npre.2016.14.5.224
Abstract
Cardiovascular disease (CVD) accounts for approximately one-third of deaths in England and Wales, and its associated morbidity cost the NHS in England alone almost £8 million in 2010 (National Institute for Health and Care Excellence (NICE), 2014). Modifiable risk factors include hypertension, smoking and raised cholesterol level.
The Joint Formulary Committee (2016) recommends the preventative use of lipid-regulating drugs where there is a high risk of developing CVD and to prevent recurrence in those with recognised CVD
Repository Staff Only: item control page
